Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant in Idiopathic or Diabetic Gastroparesis
NCT06836557Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Jan 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tradipitant in gastroparesis, sponsored by Vanda Pharmaceuticals Inc.. Started Jan 2024; status: completed.
02
Drugs
tradipitant
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT06836557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836557.